Early Access Program From Roche for SMA Therapy Risdiplam in Europe

Feb 14, 2020, 12:00 AM

SMA News Today’s multimedia associate, Price Wooldridge, discusses an early access program from Roche for SMA therapy Risdiplam in Europe and forums Director Kevin Schaefer talks about forming friendships with his caregivers, and why he thinks this is important.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/